pyrroles has been researched along with Prostatic Hyperplasia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Egawa, S; Endo, K; Hatano, T; Ishii, G; Kishimoto, K | 1 |
Doi, T; Hashimoto, T; Iwata, M; Nagabukuro, H | 1 |
Crossland, A; Mills, IW; Patel, A; Ramonas, H | 1 |
Kaplan, SA | 1 |
1 trial(s) available for pyrroles and Prostatic Hyperplasia
Article | Year |
---|---|
Atorvastatin treatment for men with lower urinary tract symptoms and benign prostatic enlargement.
Topics: Aged; Analysis of Variance; Atorvastatin; Double-Blind Method; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Pyrroles; Quality of Life; Treatment Outcome; Urination Disorders | 2007 |
3 other study(ies) available for pyrroles and Prostatic Hyperplasia
Article | Year |
---|---|
Shrinkage of prostate volume in sunitinib-treated patients with renal cell carcinoma.
Topics: Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Carcinoma, Renal Cell; Dysuria; Endosonography; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Organ Size; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Pyrroles; Quality of Life; Sunitinib; Tomography, X-Ray Computed; Urination | 2013 |
Effects of TAK-802, a novel acetylcholinesterase inhibitor, and tamsulosin, an alpha1-adrenoceptor antagonist, and their synergistic effects on the urodynamic characteristics in a guinea-pig model of functional bladder outlet obstruction.
Topics: Acetylcholinesterase; Adrenergic alpha-Antagonists; Adrenergic beta-1 Receptor Antagonists; Animals; Cholinesterase Inhibitors; Drug Synergism; Drug Therapy, Combination; Guinea Pigs; Infusions, Intravenous; Male; Prostatic Hyperplasia; Pyrroles; Quinolones; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Urinary Retention; Urodynamics | 2005 |
Metabolic dysfunction and male pelvic health.
Topics: Atorvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metabolic Syndrome; Prostatic Hyperplasia; Pyrroles; Urination Disorders | 2007 |